Revvity Inc. $RVTY Holdings Decreased by Nomura Asset Management Co. Ltd.

Nomura Asset Management Co. Ltd. trimmed its position in Revvity Inc. (NYSE:RVTY) by 91.1% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 3,544 shares of the company’s stock after selling 36,425 shares during the quarter. Nomura Asset Management Co. Ltd.’s holdings in Revvity were worth $343,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also made changes to their positions in the company. CYBER HORNET ETFs LLC bought a new position in Revvity during the 2nd quarter worth $32,000. Cromwell Holdings LLC grew its stake in Revvity by 141.4% during the 4th quarter. Cromwell Holdings LLC now owns 338 shares of the company’s stock worth $33,000 after buying an additional 198 shares during the last quarter. MUFG Securities EMEA plc bought a new position in Revvity during the 2nd quarter worth $34,000. Headlands Technologies LLC bought a new position in Revvity during the 2nd quarter worth $49,000. Finally, Smartleaf Asset Management LLC grew its stake in Revvity by 56.8% during the 3rd quarter. Smartleaf Asset Management LLC now owns 690 shares of the company’s stock worth $58,000 after buying an additional 250 shares during the last quarter. 86.65% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of brokerages recently commented on RVTY. Stifel Nicolaus lowered their price objective on Revvity from $110.00 to $100.00 and set a “hold” rating for the company in a research note on Wednesday, May 6th. JPMorgan Chase & Co. lowered their price objective on Revvity from $96.00 to $90.00 and set a “neutral” rating for the company in a research note on Wednesday, May 6th. Robert W. Baird set a $117.00 price objective on Revvity in a research note on Wednesday, May 6th. Wall Street Zen downgraded Revvity from a “buy” rating to a “hold” rating in a research note on Saturday, April 18th. Finally, Barclays upped their price objective on Revvity from $95.00 to $105.00 and gave the stock an “equal weight” rating in a research note on Thursday, May 7th. Four investment analysts have rated the stock with a Buy rating, nine have given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, Revvity presently has a consensus rating of “Hold” and an average price target of $107.73.

Revvity Trading Down 3.8%

NYSE:RVTY opened at $98.46 on Friday. Revvity Inc. has a 1 year low of $81.22 and a 1 year high of $118.30. The stock has a market cap of $10.98 billion, a price-to-earnings ratio of 47.11, a PEG ratio of 2.24 and a beta of 1.11. The business has a fifty day moving average of $93.40 and a 200-day moving average of $97.49. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.41 and a current ratio of 1.72.

Revvity (NYSE:RVTY) last released its quarterly earnings results on Tuesday, May 5th. The company reported $1.06 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.02 by $0.04. Revvity had a return on equity of 8.00% and a net margin of 8.26%.The company had revenue of $711.12 million during the quarter, compared to analysts’ expectations of $704.07 million. During the same quarter in the prior year, the business posted $1.01 earnings per share. The company’s revenue for the quarter was up 7.0% compared to the same quarter last year. Revvity has set its FY 2026 guidance at 5.200-5.300 EPS. Equities analysts predict that Revvity Inc. will post 5.25 earnings per share for the current year.

Revvity Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, August 7th. Stockholders of record on Friday, July 17th will be paid a $0.07 dividend. The ex-dividend date of this dividend is Friday, July 17th. This represents a $0.28 annualized dividend and a dividend yield of 0.3%. Revvity’s dividend payout ratio is presently 13.40%.

Revvity Company Profile

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.